Authors
Loading...
Analysis reveals that FLT3-ITD alters immune regulation and promotes disease persistence in acute myeloid leukemia, highlighting potential for immunotherapy.
Adjafre et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: